Question

Which nursing consideration(s) would be taken into account prior to the administration of cisplatin IV? (Select all that apply.)

a. Review of laboratory data for presence of myelosuppression and hepatic and renal parameters
b. Administration of IV hydration as prescribed
c. Administration of epoetin alfa (Epogen)
d. Administration of prechemotherapy mesna (Mesnex)
e. Assessment for dermatologic conditions

Answer 1

Before administering cisplatin IV, it is crucial to review laboratory data for myelosuppression and liver and kidney function, administer IV hydration, and assess for dermatologic conditions. Premedications like epoetin alfa and mesna are not standard care for cisplatin administration.

Step-by-step explanation:

Before the administration of cisplatin IV, there are specific nursing considerations that must be taken into account to ensure patient safety and the effectiveness of the medication. These considerations include:

a. Review of laboratory data for the presence of myelosuppression and hepatic and renal parameters to avoid toxicity.

b. Administration of IV hydration as prescribed to prevent nephrotoxicity, a common side effect of cisplatin, by maintaining adequate renal function.

e. An assessment for dermatologic conditions as they can be exacerbated by chemotherapy and may affect patient comfort or medication efficacy.

The administration of epoetin alfa and mesna are not standard premedications for cisplatin; epoetin alfa is used to treat anemia, typically not as a preventive measure before chemotherapy, and mesna is utilized to prevent hemorrhagic cystitis with medications such as cyclophosphamide and ifosfamide, not cisplatin.